Advertisement

Diseases of the Colon & Rectum

, Volume 41, Issue 4, pp 451–459 | Cite as

Perioperative blood transfusions reduce long-term survival following surgery for colorectal cancer

  • Tom-H. Edna
  • Tormod Bjerkeset
Original Contributions

Abstract

PURPOSE: The aim of the study contained herein was to investigate the association between blood transfusion and long-term outcome for patients treated for colorectal cancer, controlling for the effect of other prognostic factors. We also wanted to study whether blood storage time influenced the prognosis. METHODS: Cox's proportional hazards regression analysis was used to analyze data from 336 patients who survived resection with curative intent. Median follow-up was 5.8 (2-16.8) years or until death. RESULTS: Local recurrences and distant metastases were significantly more frequent when more than two units of blood had been transfused. In the multivariate Cox's analysis, with backward elimination of nonsignificant factors at the 10 percent level, the following risk factors were significantly related to death by colorectal cancer: tumor stage (T stage and N stage), perforation of tumor, age, and the need for a blood transfusion. Transfusions of more than two units of blood were independently and significantly associated with death from colorectal cancer (relative hazard, 2.7; 95 percent confidence intervals, 1.4–5.2). Time of blood storage had no effect on the prognoses. In patients dying from diseases unrelated to colorectal cancer, age and American Society of Anesthesiologists group were significantly related to death, whereas blood transfusion was not. CONCLUSION: We found an independent and significant association between perioperative blood transfusion and poor prognosis in colorectal cancer patients. Blood storage time was not a prognostic factor.

Key words

Colorectal cancer Long-term survival Prognostic factors Blood transfusion Blood storage time 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gantt CL. Red cells for cancer patients. Lancet 1981;2:363.Google Scholar
  2. 2.
    Burrows L, Tartter P. Effect of blood transfusions on colonic malignancy rate. Lancet 1982;2:662.Google Scholar
  3. 3.
    Chesi R, Cazzola B, Bacci G, Borghi B, Balladelli A, Urso G. Effect of perioperative transfusions on survival in osteosarcoma treated by multimodal therapy. Cancer 1989;64:1727–37.Google Scholar
  4. 4.
    Edna T-H, Vada K, Hesselberg F, Mjølnerød OK. Blood transfusion and survival following surgery for renal carcinoma. Br J Urol 1992;21:1165–7.Google Scholar
  5. 5.
    Maeta M, Shimizu N, Oka A,et al. Perioperative allogeneic blood transfusion exacerbates surgical stress-induced postoperative immunosuppression and has a negative effect on prognosis in patients with gastric cancer. J Surg Oncol 1994;55:149–53.Google Scholar
  6. 6.
    McClinton S, Moffat LE, Scott S, Urbaniak, SJ, Kerridge DF. Blood transfusion and survival following surgery for prostatic carcinoma. Br J Surg 1990;77:140–2.Google Scholar
  7. 7.
    McGehee RP, Dodson MK, Moore JL,et al. Effect of blood transfusion in patients with gynecologic malignancy. Int J Gynaecol Obstet 1994;46:45–52.Google Scholar
  8. 8.
    Stephenson KR, Steinberg SM, Hughes KS, Vetto JT, Sugarbaker PH, Chang AE. Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases. Ann Surg 1988;208:679–87.Google Scholar
  9. 9.
    Wolters U, Stutzer H, Keller HW, Schroder U, Pichlmaier H. Colorectal cancer—a multivariate analysis of prognostic factors. Eur J Surg Oncol 1996;22:592–7.Google Scholar
  10. 10.
    Yamamoto J, Kosuge T, Takayama T,ea al. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery 1994;115:303–9.Google Scholar
  11. 11.
    Choi JH, Chung HC, Yoo NC,et al. Perioperative blood transfusions and prognosis in patients with curatively resected locally advanced gastric cancer. Oncology 1995;52:170–5.Google Scholar
  12. 12.
    Eickhoff JH, Andersen J, Laybourn C, The Danish Breast Cancer Cooperative Group. Perioperative blood transfusion does not promote recurrence and death after mastectomy for breast cancer. Br J Surg 1991;78:1358–61.Google Scholar
  13. 13.
    Rainio P, Bloigu R, Satta J, Pokela R, Paakko P. Ten-year survival after resection for lung carcinoma: effect of blood transfusion and tumour stage on outcome. Scand J Thorac Cardiovasc Surg 1996;30:87–91.Google Scholar
  14. 14.
    Swischer SG, Holmes EC, Hunt KK, Gornbein JA, Zinner MJ, McFadden DW. Perioperative blood transfusions and decreased long term survival in esophageal cancer. J Thorac Cardiovasc Surg 1996;112:341–8.Google Scholar
  15. 15.
    Velagapudi SR, Frydenberg M, Oesterling JE,et al. Homologous blood transfusion in patients with prostate cancer: no effect on tumor progression or survival. Urology 1994;43:821–7.Google Scholar
  16. 16.
    Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994;84:1703–21.Google Scholar
  17. 17.
    Blumberg N, Heal JM. Effects of transfusion on immune function. Arch Pathol Lab Med 1994;118:371–9.Google Scholar
  18. 18.
    Houbiers JG, Busch OR, Van de Watering LM,et al. Blood transfusion in cancer surgery: a consensus statement. Eur J Surg 1995;161:307–14.Google Scholar
  19. 19.
    Hoh H, Umpleby H, Cooper A, Taylor I. Recurrence of colorectal cancer and perioperative blood transfusion: is storage time important? Dis Colon Rectum 1990;33:127–30.Google Scholar
  20. 20.
    Nielsen HJ, Reimert CM, Pedersen AN,et al. Time-dependent, spontaneous release of white cell- and platelet-derived bioactive substances from stored human blood. Transfusion 1996;36:960–5.Google Scholar
  21. 21.
    McArdle CS, Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. BMJ 1991;302:1501–5.Google Scholar
  22. 22.
    Turnbull RB Jr, Kyle K, Watson FR, Spratt J. Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann Surg 1967;166:420–7.Google Scholar
  23. 23.
    Beynon J, Davies PW, Billings PJ,et al. Perioperative blood transfusion increases the risk of recurrence in colorectal cancer. Dis Colon Rectum 1989;32:975–9.Google Scholar
  24. 24.
    Busch OR, Hop WC, Hoynck van Papendrecht MA, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993;328:1372–6.Google Scholar
  25. 25.
    Heiss MM, Mempel W, Delanoff C,et al. Blood transfusion—modulated tumor recurrence: first results of randomized study of autologousversus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994;12:1859–67.Google Scholar
  26. 26.
    Liewald F, Wirsching RP, Zulke C, Demmel N, Mempel W. Influence of blood transfusion on tumor recurrence and survival rate in colorectal carcinoma. Eur J Cancer 1990;26:327–35.Google Scholar
  27. 27.
    Tartter PI. The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg 1992;216:633–8.Google Scholar
  28. 28.
    van Lawick van Pabst WP, Langenhorst BL, Mulder PG, Marquet RL, Jeekel J. Effect of perioperative blood loss and perioperative blood transfusions on colorectal cancer survival. Eur J Cancer Clin Oncol 1988;24:741–7.Google Scholar
  29. 29.
    Bentzen SM, Balslev I, Pedersen M,et al. Blood transfusion and prognosis in Dukes' B and C colorectal cancer. Eur J Cancer 1990;26:457–63.Google Scholar
  30. 30.
    Donohue JH, Williams S, Cha S,et al. Perioperative blood transfusions do not affect disease recurrence of patients undergoing curative resection of colorectal carcinoma: a Mayo/North Central Cancer Treatment Group study. J Clin Oncol 1995;13:1671–8.Google Scholar
  31. 31.
    Modin S, Karlsson G, Wahlby L, Wahlby L. Blood transfusion and recurrence of colorectal cancer. Eur J Surg 1992;158:371–5.Google Scholar
  32. 32.
    Molland G, Dent OF, Chapuis PH, Bokey EL, Nicholls M, Newland RC. Transfusion does not influence patient survival after resection of colorectal cancer. Aust N Z J Surg 1995;65:592–5.Google Scholar
  33. 33.
    Sibbering DM, Locker AP, Hardcastle JD, Armitage NC. Blood transfusion and survival in colorectal cancer. Dis Colon Rectum 1994;37:358–63.Google Scholar
  34. 34.
    Steup WH, Hojo K, Moriya Y,et al. An analysis of the effect of blood transfusion on recurrence and survival in patients undergoing extended lymphadenectomy for colorectal cancer. Hepatogastroenterology 1994;41:253–9.Google Scholar
  35. 35.
    Heiss MM, Allgayer H, Gruetzner KU,et al. Prognostic influence of blood transfusion on minimal residual disease in resected gastric cancer patients. Anticancer Res 1997;17:2657–61.Google Scholar
  36. 36.
    Busch OR, Hop WC, Marquet RL, Jeekel J. The effect of blood transfusion on survival after surgery for colorectal cancer. Eur J Cancer 1995;31A:1226–8.Google Scholar
  37. 37.
    Brown DC, Purushotham AD, Birnie GD, George WD. Detection of intraoperative tumor cell dissemination in patients with breast cancer by use of reverse transcription and polymerase chain reaction. Surgery 1995;117:95–101.Google Scholar
  38. 38.
    Mori M, Mimori K, Ueo H,et al. Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int J Cancer 1996;68:739–43.Google Scholar
  39. 39.
    Oefelein MG, Kaul K, Herz B,et al. Molecular detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy. J Urol 1996;155:238–42.Google Scholar
  40. 40.
    Funaki NO, Tanaka J, Itami A,et al. Detection of colorectal carcinoma cells in circulating peripheral blood by reverse transcription-polymerase chain reaction targeting cytokeratin-20 mRNA. Life Sci 1997;60:643–52.Google Scholar
  41. 41.
    Tuszynski GP, Wang TN, Berger D. Adhesive proteins and the hematogenous spread of cancer. Acta Haematol 1997;97:29–39.Google Scholar
  42. 42.
    Brittenden J, Heys SD, Ross J, Eremin O. Natural killer cells and cancer. Cancer 1996;77:1226–43.Google Scholar
  43. 43.
    Braga M, Gianotti L, Vignali A,et al. Evaluation of recombinant human erythropoietin to facilitate autologous blood donation before surgery in anaemic patients with cancer of the gastrointestinal tract. Br J Surg 1995;82:1637–40.Google Scholar
  44. 44.
    Braga M, Gianotti L, Gentilini O, Vignali A, Di Carlo V. Erythropoietic response induced by recombinant human erythropoietin in anemic cancer patients candidate to major abdominal surgery. Hepatogastroenterology 1997;44:685–90.Google Scholar
  45. 45.
    Adamson J. Erythropoietin, iron metabolism, and red blood cell production. Semin Hematol 1997;33(Suppl 2):5–7.Google Scholar
  46. 46.
    Mielke LL, Entholzner EK, Kling M,et al. Preoperative acute hypervolemic hemodilution with hydroxyethylstarch: an alternative to acute normovolemic hemodilution? Anesth Analg 1997;84:26–30.Google Scholar
  47. 47.
    Kongsgaard UE, Wang MY, Kvalheim G. Leucocyte depletion filter removes cancer cells in human blood. Acta Anaesthesiol Scand 1996;40:118–20.Google Scholar
  48. 48.
    Norfolk DR, Williamson LM. Leucodepletion of blood products by filtration. Blood Rev 1995;9:7–14.Google Scholar
  49. 49.
    Jensen LS, Kissmeyer-Nielsen Å, Wolff B, Qvist N. Randomized comparison of leucocyte-depletedversus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996;348:841–5.Google Scholar
  50. 50.
    Gulliksson H, Karlman G, Segerling A, Gullbring B. Preservation of red blood cells: content of microaggregates and di-2-ethylexylphtalate (DEHP) in red blood cells stored in saline-adenine-glucose-mannitol (SAGM) medium. Vox Sang 1986;50:16–20.Google Scholar
  51. 51.
    De Cannière L, Rosière A, Michel LA. Synchronous abdominoperineal resection without transfusion. Br J Surg 1993;80:1194–5.Google Scholar

Copyright information

© the American Society of Colon and Rectal Surgeons 1988

Authors and Affiliations

  • Tom-H. Edna
    • 1
  • Tormod Bjerkeset
    • 1
  1. 1.Department of SurgeryInnherred HospitalLevangerNorway

Personalised recommendations